What it may be used for
Other wellness/body-composition uses are not the same as its approved indication and require careful clinical/regulatory review.
Peptide formulation; approved uses differ from compounded/off-label uses
Prescription treatment is never guaranteed. A licensed clinician decides what is appropriate; a pharmacy confirms formulation and availability.
Tesamorelin is a growth-hormone-releasing factor analogue with a specific FDA-approved indication for reducing excess abdominal fat in certain adults with HIV-associated lipodystrophy.
Other wellness/body-composition uses are not the same as its approved indication and require careful clinical/regulatory review.
Use only according to the prescription and product-specific instructions. Compounded formulations are not interchangeable with an approved product by assumption.
Potential effects include injection-site reactions, joint/muscle pain, swelling, glucose changes and increased IGF-1.
No general food workaround replaces product-specific instructions.
Discuss cancer history, pituitary/hypothalamic disorders, pregnancy, diabetes/glucose intolerance and elevated IGF-1.
Compounded formulations are not FDA-approved as finished products. Availability and legal status vary by jurisdiction and patient-specific need.
These are formulations/strengths found in the supplied pharmacy-partner catalog. They are shown for transparency and are not a dosing recommendation. Country, prescription, clinical appropriateness and pharmacy availability determine what can actually be dispensed.
That answer belongs on your prescription label, not on a marketing page. Doses can change with the indication, formulation, concentration, other medicines, kidney/liver function and your clinician’s plan. eHealthMedic is designed to send your assessment to the correct licensed provider for your country, then route an authorized prescription to the configured pharmacy partner.
Tell us where you live and answer a private health assessment. Your request will be routed to the appropriate country-specific clinical provider once that integration is connected.